Author

Chiho Koi

Observed names: C. Koi, CHIHO KOI

Observed institutions: Johns Hopkins University, University of Occupational and Environmental Health Japan, Johns Hopkins Medicine, Hamanomachi Hospital, Federation of National Public Service Personnel Mutual Aid Associations

ORCID: 0009-0002-8324-9591

Observed ORCID: 0009-0002-8324-9591

OpenAlex ID: A5031696571

Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer

2019 · Toshiya Abe, Chiho Koi, et al. · Clinical Gastroenterology and Hepatology · 60

Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges

2023 · Mohamad Dbouk, Toshiya Abe, et al. · Clinical Cancer Research · 37

PDF

Endoplasmic stress‐inducing variants in CPB1 and CPA1 and risk of pancreatic cancer: A case‐control study and meta‐analysis

2021 · Makoto Kawamoto, Shiro Kohi, et al. · International Journal of Cancer · 25

Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing

2020 · Anne Macgregor-Das, Jun Yu, et al. · Journal of Molecular Diagnostics · 23

GalNAc-T6 in the relationship with invasion ability of endometrial carcinomas and prognostic significance.

2017 · Thuy Thi Nguyen, Tomoko Kurita, et al. · PubMed · 15

UBE2L6 is Involved in Cisplatin Resistance by Regulating the Transcription of ABCB6

2020 · Midori Murakami, Hiroto Izumi, et al. · Anti-Cancer Agents in Medicinal Chemistry · 14

Lovastatin induced Kruppel like factor 2 (KLF2), Kruppel like factor 6 (KLF6) and Ras homolog family member B (RHOB) genes and preferentially led to viability reduction of Cisplatin-resistant cells

2017 · Chiho Koi, Hiroto Izumi, et al. · Oncotarget · 10

PDF

Overexpression of p53 in the endometrial gland in postmenopausal women

2014 · Chiho Koi, Toru Hachisuga, et al. · Menopause The Journal of The North American Menopause Society · 10

In vitro evaluation of a combination treatment involving anticancer agents and an aurora kinase B inhibitor

2016 · Senna Sakai, Hiroto Izumi, et al. · Oncology Letters · 8

PDF

A case of ovarian yolk sac tumor associated with endometrioid adenocarcinoma

2014 · Chiho Koi, Tomoko Kurita, et al. · Gynecologic Oncology Case Reports · 8

17β-Estradiol induces proliferation of endometrial NK cells (CD56+) in postmenopausal women

2017 · T. Sho, T. Hachisuga, et al. · Climacteric · 7

Expression of N-Acetylgalactosaminyltransferase-6 Is Related to Expression of Cell Adhesion Molecules in Endometrial Cancer

2017 · TOMOKO KURITA, THUY NGUYEN THI, et al. · Anticancer Research · 7

PDF

Association of UBE2L6 and ABCB6 Expression With Platinum Resistance in Serous Ovarian Carcinoma

2023 · MAMI SHIBAHARA, TOMOKO KURITA, et al. · Anticancer Research · 6

PDF

The Relationship between Positive Peritoneal Cytology and the Prognosis of Patients with Uterine Cervical Cancer

2015 · Tomoko Kurita, Yusuke Matsuura, et al. · Acta Cytologica · 5

Expression of Polypeptide N-Acetylgalactosaminyltransferase-6 in Epithelial Ovarian Carcinoma

2017 · MIDORI MURAKAMI, SEIJI KAGAMI, et al. · Anticancer Research · 3

PDF

Sal-Like Protein 4-Negative Gestational Trophoblastic Neoplasia

2023 · Chiho Koi, Reiko Yoneda, et al. · Journal of Clinical Gynecology and Obstetrics · 1

PDF

Data from Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges

2023 · Mohamad Dbouk, Toshiya Abe, et al. · 1

Supplementary Data 1 from Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges

2025 · Mohamad Dbouk, Toshiya Abe, et al.

Supplementary Data Tables S1-S5 from Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges

2025 · Mohamad Dbouk, Toshiya Abe, et al.

Supplementary Data 2 from Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges

2025 · Mohamad Dbouk, Toshiya Abe, et al.

PDF

Supplementary Data Tables S1-S5 from Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19-9 Reference Ranges